Is There a Tirzepatide Oral Solution Available in the UK?

Why do people search for a tirzepatide oral solution?

The question usually starts in one of two places: someone has read about compounded or reconstituted tirzepatide circulating in the US, or they have come across a product labelled "tirzepatide oral solution" sold through social media or overseas websites. It is worth being precise about what those products are.

In some countries, pharmacies compound their own versions of tirzepatide, sometimes as injectable solutions requiring reconstitution before use. The phrase "oral solution" has also attached itself to unlicensed liquid preparations sold online. Neither route is approved in the UK. The MHRA licenses medicines individually; a compounded or imported version does not inherit the licence of the branded product. You can read more about tirzepatide's licensed form on the tirzepatide information page.

There is also a separate, legitimate question sitting behind some of these searches: is there any oral form of a GLP-1 medicine available in the UK? The answer to that is yes, but it is semaglutide, not tirzepatide. Wegovy tablets were approved by the MHRA on 11 June 2026, making the UK the first country in Europe to license an oral GLP-1 for weight management. Tirzepatide tablets do not yet exist as a licensed product anywhere in the world.

If you are curious whether a tirzepatide oral form might follow, the page on oral tirzepatide covers the current state of research.

What are the risks of unlicensed tirzepatide solutions?

Unlicensed liquid preparations described as tirzepatide oral solutions raise serious safety concerns, and the MHRA has been consistent on this. Fake and unregulated weight-loss products sold online have, in documented cases, contained the wrong substance entirely, in some counterfeit injectable pens, insulin was found instead of the labelled medicine. A liquid product with no regulatory oversight carries the same fundamental problem: there is no independent verification of what is actually in it, at what concentration, or how stable it is.

Dosing is the other issue. The licensed Mounjaro KwikPen delivers a precise, pre-set dose. A liquid preparation requires the person to measure and, in some cases, mix the dose themselves, a process where errors can have real clinical consequences. The MHRA's guidance on GLP-1 medicines makes clear that these are not medicines to self-source without a clinical assessment and a verified supply chain. You can report any suspect product at the MHRA's Yellow Card scheme.

For anyone who has come across a product labelled "Cvreoz tirzepatide oral solution", the dedicated page on Cvreoz tirzepatide explains what that product actually is and why it is not a UK-licensed medicine.

What does licensed tirzepatide look like, and who can access it?

Licensed tirzepatide in the UK is Mounjaro, a once-weekly injection administered under the skin of the abdomen, thigh or upper arm, using a pre-filled pen. Treatment starts at 2.5 mg, a tolerability dose whose job is to let your body adjust gradually before the prescriber considers increasing it. The licensed strengths run from 2.5 mg up to 15 mg, in six steps. The NHS medicines page for tirzepatide covers the licensed form, common side effects and how the injection works in plain language.

Eligibility for private treatment follows the licensed criteria: adults with a BMI of 30 or above, or 27 or above with at least one weight-related condition such as high blood pressure, raised cholesterol or type 2 diabetes. BMI alone is not the whole picture, a prescriber looks at your medical history, current medicines and any contraindications before a prescription is written. Lower BMI thresholds apply for some ethnic backgrounds under UK clinical guidance.

The context of cost is relevant here too. Because unlicensed liquid preparations are sometimes marketed at prices well below the licensed product, it can look like a bargain. It is not. For more on what private treatment genuinely costs and what that price should include, the Mounjaro price comparison page sets out the UK market honestly.

Mounjaro is available as a private prescription through a GPhC-registered pharmacy, no GP referral, no NHS waiting list. A prescriber reviews your consultation the same day, and if approved, treatment is dispatched for free next-working-day delivery. The full picture of how Mounjaro works is on the Mounjaro overview page.

Should I be concerned if I have already used an oral tirzepatide product?

If you have taken something sold as a tirzepatide oral solution or tirzepatide weight loss oral solution and you are uncertain what it contained, speaking to a GP or pharmacist is the sensible next step, and you may also find it useful to read what others have shared in tirzepatide oral solution reviews about their experiences with these products. Side effects from an unlicensed or mislabelled product may not follow the pattern you would expect from the licensed medicine, which makes it harder to know what you are experiencing.

The most common side effects of licensed tirzepatide are gastrointestinal (nausea, loose stools, indigestion and similar) and typically settle as the body adjusts. Severe or persistent stomach pain, especially if it extends towards the back, warrants prompt medical attention. If you are considering moving to a licensed, clinically supervised route, our frequently asked questions cover what the transfer process involves, and you are welcome to get in touch with the clinical team directly. People who have been on previous treatment are reviewed carefully; evidence of current dosing is part of that process. No prescription is written without a full clinical assessment, that is not a formality, it is the point.